血管质量倡议评估颅外脑血管疾病管理对血管外科学会临床实践指南的依从性
研究利用血管质量倡议(VQI)注册数据评估2021年血管外科学会(SVS)颅外脑血管疾病临床实践指南的依从性及其对结局的影响。11条颈动脉指南推荐中4条(36%)可评估,中心层面中位依从率38%~95%,术者层面36%~100%。调整后,2条推荐依从与更低的院内卒中/死亡相关;实施文件132条推荐中仅10条(7.6%)可评估,依从性变异大,多数推荐依从与颈动脉血运重建后结局改善相关。
要点
- VQI仅能评估11条颈动脉指南推荐中的4条(36%),依从性在中心与术者间差异大。
- 低/标准手术风险无症状>70%狭窄行颈动脉内膜切除术者用最佳药物治疗,依从组院内卒中/死亡0.59% vs 非依从组1.3%(调整OR 0.44,95%CI 0.29-0.66)。
- 低/标准手术风险症状性>50%狭窄者选择颈动脉内膜切除术而非经股动脉颈动脉支架置入,依从组1.9% vs 非依从组3.4%(调整OR 0.55,95%CI 0.43-0.71)。
核心结论
- 指南依从性在VQI中心与术者间变异极大,但多数可评估推荐的依从与颈动脉血运重建后结局改善相关,应鼓励中心和术者遵循指南。
研究设计与样本
- 基于血管质量倡议(VQI)注册数据,评估2021年SVS颅外脑血管疾病临床实践指南的依从性及其对结局的影响,采用逻辑回归与逆概率加权风险调整,并按中心聚类。
- 主要结局为院内卒中/死亡的复合终点;次要分析评估2021年SVS颈动脉实施文件推荐的依从性及相关结局。
主要发现
- 11条颈动脉指南推荐中4条(36%)可利用VQI数据评估;中心层面中位依从率38%~95%,术者层面中位依从率36%~100%。
- 低/标准手术风险无症状>70%狭窄行颈动脉内膜切除术者使用最佳药物治疗(抗血小板与他汀),依从组院内卒中/死亡0.59% vs 非依从组1.3%(调整OR 0.44,95%CI 0.29-0.66)。
- 低/标准手术风险症状性>50%狭窄者行颈动脉内膜切除术而非经股动脉颈动脉支架置入,依从组院内卒中/死亡1.9% vs 非依从组3.4%(调整OR 0.55,95%CI 0.43-0.71)。
- 132条实施文件推荐中仅10条(7.6%)可利用VQI数据评估,中心与术者层面中位依从率67%~100%;仅6条(4.5%)可评估依从对结局的影响,且全部6条依从与更低的卒中/死亡相关。
关键数值与推荐
- 低/标准手术风险无症状>70%狭窄行颈动脉内膜切除术者应使用最佳药物治疗(抗血小板与他汀),依从组院内卒中/死亡0.59% vs 非依从组1.3%(调整OR 0.44,95%CI 0.29-0.66)。
- 低/标准手术风险症状性>50%狭窄者应选择颈动脉内膜切除术而非经股动脉颈动脉支架置入,依从组院内卒中/死亡1.9% vs 非依从组3.4%(调整OR 0.55,95%CI 0.43-0.71)。
临床怎么用
- 指南依从性与颈动脉血运重建后结局改善相关,应鼓励中心和术者遵循指南。
- 需优化VQI数据以促进指南依从性评估,并将这些发现传播至VQI中心和术者以推动质量改进。
局限性
- 由于推荐与VQI采集的数据变量不一致,仅少数SVS推荐可在VQI中评估。
- 132条实施文件推荐中仅10条(7.6%)可利用VQI数据评估,仅6条(4.5%)可评估依从对结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Compliance with Society for Vascular Surgery (SVS) clinical practice guidelines (CPGs) is associated with improved outcomes for the treatment of abdominal aortic aneurysm, but this has not been assessed for carotid artery disease. The Vascular Quality Initiative (VQI) registry was used to examine compliance with the SVS CPGs for the management of extracranial cerebrovascular disease and its impact on outcomes. METHODS: The 2021 SVS extracranial cerebrovascular disease CPGs were reviewed for evaluation by VQI data. Compliance rates by the center and provider were calculated, and the impact of compliance on outcomes was assessed using logistic regression with inverse probability-weighted risk adjustment for each CPG recommendation, allowing for clustering by the center. Our primary outcome was a composite end point of in-hospital stroke/death. As a secondary analysis, compliance with the 2021 SVS carotid implementation document recommendations and associated outcomes were also assessed. RESULTS: Of the 11 carotid CPG recommendations, 4 (36%) could be evaluated using VQI registry data. Median center-specific CPG compliance ranged from 38% to 95%, and median provider-specific compliance ranged from 36% to 100%. After adjustment, compliance with 2 of the recommendations was associated with lower rates of in-hospital stroke/death: first, the use of best medical therapy (antiplatelet and statin therapy) in low/standard surgical risk patients undergoing carotid endarterectomy for >70% asymptomatic stenosis (event rate in compliant vs noncompliant cases 0.59% vs 1.3%; adjusted odds ratio: 0.44, 95% confidence interval: 0.29-0.66); and second, carotid endarterectomy over transfemoral carotid artery stenting in low/standard surgical risk patients with >50% symptomatic stenosis (1.9% vs 3.4%; adjusted odds ratio: 0.55, 95% confidence interval: 0.43-0.71). Of the 132 implementation document recommendations, only 10 (7.6%) could be assessed using VQI data, with median center- and provider-specific compliance rates ranging from 67% to 100%. The impact of compliance on outcomes could only be assessed for 6 (4.5%) of these recommendations, and compliance with all 6 recommendations was associated with lower stroke/death. CONCLUSIONS: Few SVS recommendations could be assessed in the VQI because of incongruity between the recommendations and the VQI data variables collected. Although guideline compliance was extremely variable among VQI centers and providers, compliance with most of these recommendations was associated with improved outcomes after carotid revascularization. This finding confirms the value of guideline compliance, which should be encouraged for centers and providers. Optimization of VQI data to promote evaluation of guideline compliance and distribution of these findings to VQI centers and providers will help facilitate quality improvement efforts in the care of vascular patients.
引用
- Marcaccio CL, AbuRahma AF, Eldrup-Jorgensen J, et al. Vascular Quality Initiative assessment of compliance with Society for Vascular Surgery clinical practice guidelines on the management of extracranial cerebrovascular disease. J Vasc Surg. 2023. PMID: 36948279. doi:10.1016/j.jvs.2023.03.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。